- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01766349
Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer Patients
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Primary Esophagus Cancer
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Background and Purpose: Incidence rates of esophageal cancer vary internationally with the higher rate found in Eastern Asia. Preoperative concurrent chemoradiation therapy (CCRT) for resectable esophageal cancer has been shown to improve overall survival in meta-analyses. Preoperative pulmonary function and functional capacity are known predictive factors for the development of postoperative pulmonary complications in patient undergoing major cancer surgery. Little is known concerning the impacts of preoperative CCRT on pulmonary function and functional capacity in patients with esophageal cancer. The aim of this study is to examine changes of respiratory performance and functional exercise capacity during RT or CCRT, the relations between these changes, and the impacts of these changes on the postoperative outcomes in patients with esophageal cancer.
Method: Patients with newly diagnosed esophageal cancer without metastasis will be recruited from the Far Eastern Memorial Hospital. Demographic data will be obtained from the chart. Respiratory muscle strength will be measured by maximal inspiratory and expiratory pressure. Spirometric variables will be tested by force expiratory volume in one second and forced vital capacity. Dyspnea will be measured using modified Borg scale. Functional exercise capacity will be measured by six minute walk distance. Quality of life will be measured using EORTC QOL-C30 and QOL-OES18 instruments. All the measurements will be repeated weekly during the concurrent therapy period. Repeated measure ANOVA will be used for analyzing difference among various time points. Spearman correlation coefficient will be used to test relationship between multiple variables. For patients who are receiving esophagectomy after CCRT or RT, pulmonary complications and total length of hospital stay will be documented.
Clinical relevance: The results of this study will help to better understand the indications for chest physiotherapy (e.g., respiratory muscle weakness, reduced functional capacity, and their related sequels)
Studientyp
Einschreibung (Voraussichtlich)
Kontakte und Standorte
Studienorte
-
-
-
New Taipei City, Taiwan
- Far Eastern Memorial Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- primary esophagus cancer
- planning to receive radiation therapy
Exclusion Criteria:
- MMSE < 24
- A clinical diagnosis affecting respiratory muscle function and functional activity performance
- Unstable angina or acute myocardial infarction prior 1 month of assessment
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: Kohorte
- Zeitperspektiven: Interessent
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
esophagus cancer patients
Respiratory muscle performance will be followed in patients with esophagus cancer during CCRT or RT treatments.
|
Respiratory muscle performance will include measurements of respiratory muscle strength and pulmonary function testing.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Changes of respiratory muscle performance (MIP/MEP, PFT)from baseline
Zeitfenster: Baseline, during CCRT or RT treatment (Day 5, Day 10, Day 15, Day 20, Day 25), 2 weeks after the completion of the treatment, 1 day pre-operation, and 1 month after operation
|
Maximum inspiratory pressure (MIP) Maximum expiratory pressure (MEP) PFT: FEV1, FVC, FEV1/FVC
|
Baseline, during CCRT or RT treatment (Day 5, Day 10, Day 15, Day 20, Day 25), 2 weeks after the completion of the treatment, 1 day pre-operation, and 1 month after operation
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Changes of functional exercise capacity, dyspnea, and quality of life from baseline
Zeitfenster: Baseline, during CCRT or RT treatment (Day 5, Day 10, Day 15, Day 20, Day 25), 2 weeks after the completion of the treatment, 1 day pre-operation, and 1 month after operation
|
Functional exercise capacity will be measured using six-minute walk test.
Modified Borg scale will be used to measure dyspnea.
EORTC QOL-C30 and QOL-OES18 instruments will be used to measure Quality of life.
|
Baseline, during CCRT or RT treatment (Day 5, Day 10, Day 15, Day 20, Day 25), 2 weeks after the completion of the treatment, 1 day pre-operation, and 1 month after operation
|
|
Prevalence of pulmonary complications
Zeitfenster: During hospital stay after esophagectomy (average hospitalization after the operation ranges from 1 month to 3 months)
|
Data will be retrieved from the chart.
|
During hospital stay after esophagectomy (average hospitalization after the operation ranges from 1 month to 3 months)
|
|
Total length of hospital stay
Zeitfenster: During hospital stay after esophagectomy (average hospitalization after the operation ranges from 1 month to 3 months)
|
Data will be retrieved from the chart.
|
During hospital stay after esophagectomy (average hospitalization after the operation ranges from 1 month to 3 months)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Chen-Hsi Hsieh, MD., Ph.D., Department of Radiation Oncology, Far Eastern Memorial Hospital
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- FEMH-IRB-100066-E
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur respiratory muscle performance
-
Michael ChuAbgeschlossen
-
University of LjubljanaScience and Research Centre KoperAbgeschlossenKörperliche Fitness | Körperliche Untersuchung | Aerobe Kapazität | Herz-Lungen-Fitness | KampfbereitschaftSlowenien
-
Sonde HealthMontefiore Medical CenterAktiv, nicht rekrutierend
-
Respiree Pte LtdAbgeschlossenMindestens 30 Erwachsene ab 18 JahrenVereinigte Staaten
-
QIAGEN Gaithersburg, IncAbgeschlossenAtemwegserkrankungVereinigtes Königreich
-
University of South CarolinaMAXIMUSAbgeschlossen
-
Aptitude Medical SystemsNoch keine RekrutierungGrippe A | Rhinovirus | RSV | Influenza B | Respiratory Synctial Virus | COVID 19Vereinigte Staaten
-
Guy's and St Thomas' NHS Foundation TrustPhilips HealthcareAbgeschlossen
-
The Cooper Health SystemThe Cooper FoundationNoch keine RekrutierungKnochenmarktransplantation - autolog oder allogen | CAR-T-Zelltherapie | RSV-ImmunisierungVereinigte Staaten
-
Superior UniversityAktiv, nicht rekrutierend